|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12Q 1/68 | (2006.01) |
| A61K 31/00 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 1567667 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03778516.9 |
| Date of filing the European patent application | 2003-11-26 | |
| (97) | Date of publication of the European application | 2005-08-31 |
| (45) | Date of publication and mention of the grant of the patent | 2008-10-15 |
| (46) | Date of publication of the claims translation | 2009-04-27 |
| (86) | Number | PCT/GB2003/005131 |
| Date | 2003-11-26 |
| (87) | Number | WO 2004/050913 |
| Date | 2004-06-17 |
| (30) | Number | Date | Country code |
| 0228079 | 2002-12-02 | GB |
| (72) |
HORROBIN, David Frederick, GB
|
| (73) |
Amarin Neuroscience Limited,
Kings Park House Laurelhill Business Park Polmaise Road, Stirling FK7 9JQ,
GB
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Huntington'o ligos gydymas eikozapentaenoine rūgštimi |
| TREATMENT OF HUNTINGTON`S DISEASE WITH EPA |
| Payment date | Validity (years) | Amount | |
| 2009-10-08 | 7 | 560.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2010-11-26 |